CVS Health Corp (CVS-N) Stock Predictions - Stockchase
WATCH LIST
217
CVS Health Corp (CVS-N)

ON STOCKCHASE SINCE Dec 2001

retail drug store chain

specialty stores

CVS Health Corp

CVS-N

66 watching          
Join the Discussion

CVS Health Corp (CVS-N) SAVE Apr, 19, 2019, 5:02 am

52.63 0.09 (0.17%)

About CVS Health Corp (CVS-N)

CVS Health is an American retail pharmacy and health care company headquartered in Woonsocket, Rhode Island. More at Wikipedia

What the experts are saying about CVS-N



  • All
  • Filtered
Signal Opinion Expert
WEAK BUY
CVS Health Corp(CVS-N) 

April 5, 2018

It scores in the top percent as a cheap stock but in the bottom in term of price momentum.  It is a value stock at this point.

specialty stores
0 0 0 0 0
0 comments

It scores in the top percent as a cheap stock but in the bottom in term of price momentum.  It is a value stock at this point.

specialty stores
0 0 0 0 0
0 comments
Jason Mann

CIO & Co-F, Edgehill Patners...

Price Price
$64.660
Owned Owned
Unknown

TOP PICK
CVS Health Corp(CVS-N) 

March 28, 2018

It is only 10 times earnings and great value here.  Concerns of Amazon entering into drug distribution appear to be fading due to the strict regulatory requirements.  Once their recent acquisition is completed, they will be able to deleverage themselves.  Yield 3.2%.  (Analysts’ price target is $88.85 )

specialty stores
0 0 0 0 0
0 comments

It is only 10 times earnings and great value here.  Concerns of Amazon entering into drug distribution appear to be fading due to the strict regulatory requirements.  Once their recent acquisition is completed, they will be able to deleverage themselves.  Yield 3.2%.  (Analysts’ price target is $88.85 )

specialty stores
0 0 0 0 0
0 comments
Michael Simpson

Senior Vic, Sentry Investments...

Price Price
$62.710
Owned Owned
Yes

PAST TOP PICK
CVS Health Corp(CVS-N) 

March 28, 2018

(A Top Pick January 20/17 Down 22%). A recent acquisition of a health insurer still needs to be approved by regulators.  It trades about 10 times earnings.   He expects them to be able purchase shares back and sees it trading at excellent value here.  A well-run company. 

specialty stores
0 0 0 0 0
0 comments

(A Top Pick January 20/17 Down 22%). A recent acquisition of a health insurer still needs to be approved by regulators.  It trades about 10 times earnings.   He expects them to be able purchase shares back and sees it trading at excellent value here.  A well-run company. 

specialty stores
0 0 0 0 0
0 comments
Michael Simpson

Senior Vic, Sentry Investments...

Price Price
$62.710
Owned Owned
Yes

DON'T BUY
CVS Health Corp(CVS-N) 

March 19, 2018

He's been hard on this name. He's steered away from consumer staples, a bad neighbourhood. Its retail end has done OK due to consistent demand, but its pharmacy side has struggled. Generic drug pricing pressure is merely one factor. Its dividend isn't enough to make him buy. He could see a pullback when rates rise; inflation hurts bond proxies like this.

specialty stores
0 0 0 0 0
0 comments

He's been hard on this name. He's steered away from consumer staples, a bad neighbourhood. Its retail end has done OK due to consistent demand, but its pharmacy side has struggled. Generic drug pricing pressure is merely one factor. Its dividend isn't enough to make him buy. He could see a pullback when rates rise; inflation hurts bond proxies like this.

specialty stores
0 0 0 0 0
0 comments
Cameron Hurst

Chief Inve, Equium Capital Manag...

Price Price
$63.630
Owned Owned
No

BUY
CVS Health Corp(CVS-N) 

March 14, 2018

This will reward patient investors. A highly-disrupted business, having just bought insurer Aetna for vertical integration. They are redefining themselves by locating a store within 3 miles of 80% of the US population, a population that now must take care of chronic ailments, like diabetes. So, this proximity to customers is efficient and profitable. Trading at 11x earnings with good cash flow despite current debt levels. Also likes competitor Walgreens.

specialty stores
0 0 0 0 0
0 comments

This will reward patient investors. A highly-disrupted business, having just bought insurer Aetna for vertical integration. They are redefining themselves by locating a store within 3 miles of 80% of the US population, a population that now must take care of chronic ailments, like diabetes. So, this proximity to customers is efficient and profitable. Trading at 11x earnings with good cash flow despite current debt levels. Also likes competitor Walgreens.

specialty stores
0 0 0 0 0
0 comments
Gordon Reid

President, GoodReid Investment ...

Price Price
$67.050
Owned Owned
Yes

BUY on WEAKNESS
CVS Health Corp(CVS-N) 

March 14, 2018

He thinks as a value investor you have to be careful.  However, he thinks $59.82 would be a great buy price.  He would wait until a pullback and sees $88 as a target.

specialty stores
0 0 0 0 0
0 comments

He thinks as a value investor you have to be careful.  However, he thinks $59.82 would be a great buy price.  He would wait until a pullback and sees $88 as a target.

specialty stores
0 0 0 0 0
0 comments
Brian Acker, CA

Chief Exec, Acker Finley Inc....

Price Price
$67.050
Owned Owned
Yes

BUY
CVS Health Corp(CVS-N) 

March 13, 2018

(At the time of this comment, Aetna holders have just approved the deal with CVS.) This is a very large company. It’s underperforming most other large companies. It hit a solid bottom of about $66 and so it’s at a good buy point, $68, at the low end of its range. Volume is not terrific. You definitely want to get out if it falls below $66. If you buy this now, the first expectations would be a $4 gain, with potential rise of another $5 to $6. (Analysts’ price target is 80.21$)

specialty stores
0 0 0 0 0
0 comments

(At the time of this comment, Aetna holders have just approved the deal with CVS.) This is a very large company. It’s underperforming most other large companies. It hit a solid bottom of about $66 and so it’s at a good buy point, $68, at the low end of its range. Volume is not terrific. You definitely want to get out if it falls below $66. If you buy this now, the first expectations would be a $4 gain, with potential rise of another $5 to $6. (Analysts’ price target is 80.21$)

specialty stores
0 0 0 0 0
0 comments
Jeff Parent B.

VP & Portf, Castlemoore Inc....

Price Price
$68.250
Owned Owned
Unknown

COMMENT
CVS Health Corp(CVS-N) 

February 15, 2018

CVS Health Corp (CVS-N) vs Walgreen Boots Alliance (WBA-O) or stay out of health care? He prefers Walgreen between the two, due to their Rite Aid acquisition. They feel that a safer option is AmerisourceBergen (ABC-N) as they are more on the distribution side. (Analysts’ price target is $89)

specialty stores
0 0 0 0 0
0 comments

CVS Health Corp (CVS-N) vs Walgreen Boots Alliance (WBA-O) or stay out of health care? He prefers Walgreen between the two, due to their Rite Aid acquisition. They feel that a safer option is AmerisourceBergen (ABC-N) as they are more on the distribution side. (Analysts’ price target is $89)

specialty stores
0 0 0 0 0
0 comments
Mario Mainelli,

Portfolio , Caldwell Investment ...

Price Price
$70.490
Owned Owned
Unknown

PAST TOP PICK
CVS Health Corp(CVS-N) 

February 13, 2018

(A Top Pick Feb. 16/17, Down 12%) Sold his shares last summer. Too much regulatory uncertainty and risk. more than he bargained for. Likes home healthcare, but the regulatory risk turns him off. Amazon going into the space scares the hell out of everyone, doesn't it?

specialty stores
0 0 0 0 0
0 comments

(A Top Pick Feb. 16/17, Down 12%) Sold his shares last summer. Too much regulatory uncertainty and risk. more than he bargained for. Likes home healthcare, but the regulatory risk turns him off. Amazon going into the space scares the hell out of everyone, doesn't it?

specialty stores
0 0 0 0 0
0 comments
David Baskin

President, Baskin Wealth Manage...

Price Price
$70.110
Owned Owned
No

BUY
CVS Health Corp(CVS-N) 

February 2, 2018

A lot of pressure from Amazon getting into CVS' space, but confident CVS will emerge well. CVS will fight back. But don't get too speculative on events (Amazon) that could happen. ROIC consistent. Good valuation. He has faith in CVS.

specialty stores
0 0 0 0 0
0 comments

A lot of pressure from Amazon getting into CVS' space, but confident CVS will emerge well. CVS will fight back. But don't get too speculative on events (Amazon) that could happen. ROIC consistent. Good valuation. He has faith in CVS.

specialty stores
0 0 0 0 0
0 comments
Matt Kacur

President, FSA Financial Scienc...

Price Price
$76.450
Owned Owned
Unknown

BUY
CVS Health Corp(CVS-N) 

February 1, 2018

It is not like Shoppers Drug Mart like some people believe it is. They are more an integrated health care company rather than retail. Some of the issues they had with the CVS part of the business have stabilized. It makes sense in the Health Care space to be vertically integrated. Over the long run is going to do well particularly if they integrate ETNA well. On top of that the tax cuts will help them as they are mostly domestic (Analysts' price target $89).

specialty stores
0 0 0 0 0
0 comments

It is not like Shoppers Drug Mart like some people believe it is. They are more an integrated health care company rather than retail. Some of the issues they had with the CVS part of the business have stabilized. It makes sense in the Health Care space to be vertically integrated. Over the long run is going to do well particularly if they integrate ETNA well. On top of that the tax cuts will help them as they are mostly domestic (Analysts' price target $89).

specialty stores
0 0 0 0 0
0 comments
Paul Harris, CF

Portfolio , Avenue Investment Ma...

Price Price
$78.790
Owned Owned
Yes

COMMENT
CVS Health Corp(CVS-N) 

January 24, 2018

The thing with this, as we have seen with a lot of stocks, is the Amazon factor. If you don't own Amazon, you are kind of behind the curve because it has done so well. However, on the flipside, if you own anything that Amazon is remotely touching, you are going to get penalized. This company falls into that category. It screens great on any kind of a value metric, but there is this huge overhang in the industry. She doesn't want to own anything that is even remotely spoken about that has an Amazon connection.

specialty stores
0 0 0 0 0
0 comments

The thing with this, as we have seen with a lot of stocks, is the Amazon factor. If you don't own Amazon, you are kind of behind the curve because it has done so well. However, on the flipside, if you own anything that Amazon is remotely touching, you are going to get penalized. This company falls into that category. It screens great on any kind of a value metric, but there is this huge overhang in the industry. She doesn't want to own anything that is even remotely spoken about that has an Amazon connection.

specialty stores
0 0 0 0 0
0 comments
Jennifer Radman

VP & Sr. P, Caldwell Investment ...

Price Price
$80.920
Owned Owned
Unknown

COMMENT
CVS Health Corp(CVS-N) 

January 18, 2018

The acquisition is a big one and because of the size there is some fear they can’t get it done.  There is more risk to this deal than normal.  It is in no man’s land otherwise.  It has not got strong price momentum, but has a good balance sheet.

specialty stores
0 0 0 0 0
0 comments

The acquisition is a big one and because of the size there is some fear they can’t get it done.  There is more risk to this deal than normal.  It is in no man’s land otherwise.  It has not got strong price momentum, but has a good balance sheet.

specialty stores
0 0 0 0 0
0 comments
Jason Mann

CIO & Co-F, Edgehill Patners...

Price Price
$79.350
Owned Owned
Unknown

COMMENT
CVS Health Corp(CVS-N) 

January 12, 2018

About 2 or 3 months ago, this got hit by the Amazon affect, and the stock fell to $66, and is now at $79. This has a positive transit of EBV +3, which is a Buy signal. His model price is $100.70, 27% upside. A good price if you are looking at buying this.

specialty stores
0 0 0 0 0
0 comments

About 2 or 3 months ago, this got hit by the Amazon affect, and the stock fell to $66, and is now at $79. This has a positive transit of EBV +3, which is a Buy signal. His model price is $100.70, 27% upside. A good price if you are looking at buying this.

specialty stores
0 0 0 0 0
0 comments
Brian Acker, CA

Chief Exec, Acker Finley Inc....

Price Price
$78.780
Owned Owned
Yes

TOP PICK
CVS Health Corp(CVS-N) 

January 12, 2018

Just made the acquisition of Aetna, which is still pending approval. There is a consistency of the business and they're spinning off an incredible amount of free cash flow and buying back a ton of stock. Had a bit of volatility through the end of the year, because of an article regarding Aetna and the multiple they were going to have to pay. There was also concern about Amazon (AMZN-Q) entering the pharmacy space. This is inexpensive relative to the rest of the market, trading at 12X earnings. Dividend yield of 2.5%. (Analysts' price target is $88.)

specialty stores
0 0 0 0 0
0 comments

Just made the acquisition of Aetna, which is still pending approval. There is a consistency of the business and they're spinning off an incredible amount of free cash flow and buying back a ton of stock. Had a bit of volatility through the end of the year, because of an article regarding Aetna and the multiple they were going to have to pay. There was also concern about Amazon (AMZN-Q) entering the pharmacy space. This is inexpensive relative to the rest of the market, trading at 12X earnings. Dividend yield of 2.5%. (Analysts' price target is $88.)

specialty stores
0 0 0 0 0
0 comments
Bryden Teich

Portfolio , Avenue Investment Ma...

Price Price
$78.780
Owned Owned
Yes

Showing 61 to 75 of 217 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days